Brazil's Big Opportunity Can't Wait for This Health Care Leader (Daily Finance)
Read S+N Press Release here
Read also... Trend contiues as Big Orthos focus on emerging markets
Remember when emerging markets were destined to make investors rich? It hasn't worked out that way in 2013 -- not after China's leading stocks have disappointed and Brazil's economy has slowed down from the lofty growth projections of a few years ago. Those can't-miss growth opportunities just haven't panned out yet for the most part.
Yet the potential is there in emerging markets, no doubt. Leading medical device firms have made big acquisitions in developing nations, led by Medtronic and Stryker in China over the past year. Orthopedics rival Smith & Nephew isn't shying away from the emerging markets game, either. It's beefed up its own exposure abroad lately with its purchase of a quarter of the business of Brazilian device firm Politic Saude. But is this the right move for this medical device giant in its emerging markets push?
Smith & Nephew makes a move
Emerging markets have been a big boon for Smith & Nephew, which has been hit with the headwinds of stiff competition and pricing pressures...
